Live performance intelligence
Explore the strategic and financial questions leaders actually ask. Hundreds of use cases.
Do not manage every line to the hospital average. Surgery and orthopedics will set that bar; medicine and GI will sit below it. Confirm contribution and the line’s role in the market before treating a lower rate as a pricing problem.
A busier month is not a better month if payment per encounter was flat. Separate volume from rate before the board briefing. A one-month drop is price or mix — not a volume story.
Most of the revenue already sits in a handful of origin ZIPs. Thin dollars at the edge of the map are an access and referral problem, not a case for new capacity.
Volume and drug cost stay still, so the dollars on the screen are what one plan’s rate is worth at the table. Negotiate that contract. Do not wait for the commercial average to follow.
Commercial and Blue Cross are funding the enterprise. Managed Medicaid sits below direct cost — that is a mission and contracting conversation, not a reflex to close the service. Price the subsidy before you change the mix.
A hospital-wide length-of-stay target hides the only lines that can move. Pulmonary runs long against its own CMS mean; orthopedics is already inside it. Work the off-benchmark lines.
Net revenue covers direct cost. Overhead is what puts operating margin under water. Name the overhead category — and whether it actually retires — before you cut a clinical service that is still contributing.
The home market and the out-of-area book are different businesses. Medicare weights north; commercial weights east. Contract and staff on the mix you actually serve in each direction, not on the system average.
When the question on the card is not the one in the room, ask the next one against the same file. Stay inside your numbers. A benchmark that is not in the data is not an answer.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
The ZIP that produces the most dollars is not always the ZIP that pays. Choose a growth market on payment rate and contribution, not on revenue alone. Volume without margin is just more work.
Charges are not contribution. Orthopedics leads the dollars that remain after direct cost. A thinner rate can still be a core line when the dollars are material and the capacity is already paid for.
Three years of higher net patient revenue and a still-positive direct margin have not produced a positive operating margin. The organization is busier, not more profitable. Volume has not yet covered overhead.
Read the multi-year change, not a single year. Inpatient allowances moved the most; swing is smaller dollars at a steeper discount. Confirm contract and mix versus a classification shift before you renegotiate.
The collection gap widened on the outpatient side, not in the hospital census. That is contracting and revenue cycle. A census initiative will not close this gap.
Put the same live figures in front of the board that the studies already produced — revenue, direct margin, operating margin, and volume. If the narrative and the number disagree, fix the story before the meeting.
Clinic is the visit engine and belongs on its own page. Outside it, the emergency department is the volume and inpatient is the stay. Manage them as different businesses, not as one average.
Occupancy is a unit fact, not a hospital fact. Med/surg can be strained while obstetrics sits open. Above a strain threshold the next question is throughput and staffing — not a replacement facility.
A large payer is not automatically a well-paid payer. Manage the relationship on net revenue and contribution, not on encounter count. Volume without payment is work you already know how to do.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
Total dollars, payment rate, and contribution per encounter will not rank the same ZIPs. A high-volume origin can still leave little after direct cost. Grow the map that contributes, not just the map that visits.
General surgery and orthopedics produce the contribution dollars; urology is smaller and still material. Add cases where contribution and available block time coincide — otherwise you buy volume you cannot staff.
This test moves volume, not rate. Implant cost per case and overhead stay put, so contribution rises by less than a model that treats every cost as variable. Take the conservative number to the growth discussion.
Orthopedics compounded across three years; general medicine stalled. A single year is a snapshot. Put capital, recruitment, and block time behind the lines that are compounding.
This is denial rate, not days in receivables. Self-pay and managed Medicaid lead; commercial at this level is a process watch. A sustained rise in commercial denials becomes a contract issue.
Direct cost is roughly flat. Indirect cost has stepped up. Closing a clinical line does not retire the overhead allocated on top of it — name what actually goes away before you take the service out.
A higher rate on lower volume is a different decision than both rising together. Do not brief a rate gain as growth. Ask whether the cases you lost were the ones you wanted to keep.
Inpatient is still under half of net revenue; outpatient surgery is the next share. Clinic is the visit count, not the dollar. Build the portfolio from where the money sits, not from where the encounters sit.
Self-pay accounts for nearly all of the bad debt. Commercial residual at this level is follow-up and denials, not a payer-strategy problem. Keep it out of the rate negotiation.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
Once acuity is out of the comparison, the gap is the contract. Workers’ compensation and commercial pay more per weighted discharge; Medicaid does not. Take the residual to negotiation — not to a case-mix discussion.
Variance to plan is not a ranking of departments. Pharmacy and implants ran over; imaging ran under. A favorable variance can be missing volume, not tighter control — separate the two before the next budget review.
One long month is seasonality. A string of months above the CMS mean is a care-process issue. Keep the external benchmark; do not reset the target to the hospital’s own average.
Orthopedics is not one business. Surgical cases and spine carry a different rate, cost, and block-time profile than clinic and nonsurgical work. Grow and staff at the subservice line, or the service-line average will hide the decision.
Traditional Medicare dollars are easing as Medicare Advantage grows. Same patients, different contract. Read each book on its own payment rate — one blended Medicare line hides the shift that needs a response.
The commercial average hides the spread that matters. Start the next negotiation with the plan that combines real volume and a weak payment rate — not with the group mean that no payer actually pays.
Discharges are flat and length of stay sits inside the CMS mean. Occupancy pressure is concentrated, not hospital-wide. Staff and open beds on the units that are actually full.
GI and orthopedics clear a contribution rate that can fund growth. Oncology looks thin because drug cost travels with the case. Expand only where rate and capacity — block time and clinic access — both exist.
Clinic is carrying the growth. Surgical volume is slightly off, and emergency volume is seasonal rather than a new trend. Judge today’s run rate against the three-year path before calling any one month a strategy.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
Rising emergency volume with flat discharges is a throughput and disposition problem, not proof the hospital needs more beds. Treat the waiting room and the inpatient census as separate questions.
Inpatient dollars eased while observation grew. That can be appropriate status, or short stays leaving the inpatient definition. Settle the clinical criteria before treating the dollar shift as leakage or a win.
Cost is not one number. Separate drugs, implants, and purchased services before setting a target. Direct contribution and fully loaded margin answer different decisions — do not use one to make the other.
Inpatient remains the larger dollar base; outpatient is where the growth sits. A softer inpatient year beside a stronger surgical year is often a site-of-care shift, not lost share. Confirm share before adding capacity or cutting a line.
A wide collection gap in self-pay belongs in charity and bad-debt policy. The same gap in commercial or Medicare is contract, denial, or underpayment. Work those two problems on different desks.
If case mix got heavier, expected stay and expected cost should have moved with it. When they did not, documentation and the clinical course are telling different stories — close that gap before the next payment review.
Procedural practices tend to lead contribution dollars; hospital medicine can lead encounters without leading payment rate. Use the view for panel, block, and recruitment planning — not as a public scorecard.
Allowances eased in both settings, and inpatient improved faster. That is not automatically a rate win. If cases also moved outpatient, the hospital average can look better while dollars left the higher-paying setting.
Ancillary departments have a margin, not only a support role. Imaging leads contribution; pharmacy is thinner because drug cost sits on the same line. Read them as businesses when you set targets, prices, and hours.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
Do not manage every line to the hospital average. Surgery and orthopedics will set that bar; medicine and GI will sit below it. Confirm contribution and the line’s role in the market before treating a lower rate as a pricing problem.
A busier month is not a better month if payment per encounter was flat. Separate volume from rate before the board briefing. A one-month drop is price or mix — not a volume story.
Most of the revenue already sits in a handful of origin ZIPs. Thin dollars at the edge of the map are an access and referral problem, not a case for new capacity.
Volume and drug cost stay still, so the dollars on the screen are what one plan’s rate is worth at the table. Negotiate that contract. Do not wait for the commercial average to follow.
Commercial and Blue Cross are funding the enterprise. Managed Medicaid sits below direct cost — that is a mission and contracting conversation, not a reflex to close the service. Price the subsidy before you change the mix.
A hospital-wide length-of-stay target hides the only lines that can move. Pulmonary runs long against its own CMS mean; orthopedics is already inside it. Work the off-benchmark lines.
Net revenue covers direct cost. Overhead is what puts operating margin under water. Name the overhead category — and whether it actually retires — before you cut a clinical service that is still contributing.
The home market and the out-of-area book are different businesses. Medicare weights north; commercial weights east. Contract and staff on the mix you actually serve in each direction, not on the system average.
When the question on the card is not the one in the room, ask the next one against the same file. Stay inside your numbers. A benchmark that is not in the data is not an answer.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
The ZIP that produces the most dollars is not always the ZIP that pays. Choose a growth market on payment rate and contribution, not on revenue alone. Volume without margin is just more work.
Charges are not contribution. Orthopedics leads the dollars that remain after direct cost. A thinner rate can still be a core line when the dollars are material and the capacity is already paid for.
Three years of higher net patient revenue and a still-positive direct margin have not produced a positive operating margin. The organization is busier, not more profitable. Volume has not yet covered overhead.
Read the multi-year change, not a single year. Inpatient allowances moved the most; swing is smaller dollars at a steeper discount. Confirm contract and mix versus a classification shift before you renegotiate.
The collection gap widened on the outpatient side, not in the hospital census. That is contracting and revenue cycle. A census initiative will not close this gap.
Put the same live figures in front of the board that the studies already produced — revenue, direct margin, operating margin, and volume. If the narrative and the number disagree, fix the story before the meeting.
Clinic is the visit engine and belongs on its own page. Outside it, the emergency department is the volume and inpatient is the stay. Manage them as different businesses, not as one average.
Occupancy is a unit fact, not a hospital fact. Med/surg can be strained while obstetrics sits open. Above a strain threshold the next question is throughput and staffing — not a replacement facility.
A large payer is not automatically a well-paid payer. Manage the relationship on net revenue and contribution, not on encounter count. Volume without payment is work you already know how to do.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
Total dollars, payment rate, and contribution per encounter will not rank the same ZIPs. A high-volume origin can still leave little after direct cost. Grow the map that contributes, not just the map that visits.
General surgery and orthopedics produce the contribution dollars; urology is smaller and still material. Add cases where contribution and available block time coincide — otherwise you buy volume you cannot staff.
This test moves volume, not rate. Implant cost per case and overhead stay put, so contribution rises by less than a model that treats every cost as variable. Take the conservative number to the growth discussion.
Orthopedics compounded across three years; general medicine stalled. A single year is a snapshot. Put capital, recruitment, and block time behind the lines that are compounding.
This is denial rate, not days in receivables. Self-pay and managed Medicaid lead; commercial at this level is a process watch. A sustained rise in commercial denials becomes a contract issue.
Direct cost is roughly flat. Indirect cost has stepped up. Closing a clinical line does not retire the overhead allocated on top of it — name what actually goes away before you take the service out.
A higher rate on lower volume is a different decision than both rising together. Do not brief a rate gain as growth. Ask whether the cases you lost were the ones you wanted to keep.
Inpatient is still under half of net revenue; outpatient surgery is the next share. Clinic is the visit count, not the dollar. Build the portfolio from where the money sits, not from where the encounters sit.
Self-pay accounts for nearly all of the bad debt. Commercial residual at this level is follow-up and denials, not a payer-strategy problem. Keep it out of the rate negotiation.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
Once acuity is out of the comparison, the gap is the contract. Workers’ compensation and commercial pay more per weighted discharge; Medicaid does not. Take the residual to negotiation — not to a case-mix discussion.
Variance to plan is not a ranking of departments. Pharmacy and implants ran over; imaging ran under. A favorable variance can be missing volume, not tighter control — separate the two before the next budget review.
One long month is seasonality. A string of months above the CMS mean is a care-process issue. Keep the external benchmark; do not reset the target to the hospital’s own average.
Orthopedics is not one business. Surgical cases and spine carry a different rate, cost, and block-time profile than clinic and nonsurgical work. Grow and staff at the subservice line, or the service-line average will hide the decision.
Traditional Medicare dollars are easing as Medicare Advantage grows. Same patients, different contract. Read each book on its own payment rate — one blended Medicare line hides the shift that needs a response.
The commercial average hides the spread that matters. Start the next negotiation with the plan that combines real volume and a weak payment rate — not with the group mean that no payer actually pays.
Discharges are flat and length of stay sits inside the CMS mean. Occupancy pressure is concentrated, not hospital-wide. Staff and open beds on the units that are actually full.
GI and orthopedics clear a contribution rate that can fund growth. Oncology looks thin because drug cost travels with the case. Expand only where rate and capacity — block time and clinic access — both exist.
Clinic is carrying the growth. Surgical volume is slightly off, and emergency volume is seasonal rather than a new trend. Judge today’s run rate against the three-year path before calling any one month a strategy.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.
Rising emergency volume with flat discharges is a throughput and disposition problem, not proof the hospital needs more beds. Treat the waiting room and the inpatient census as separate questions.
Inpatient dollars eased while observation grew. That can be appropriate status, or short stays leaving the inpatient definition. Settle the clinical criteria before treating the dollar shift as leakage or a win.
Cost is not one number. Separate drugs, implants, and purchased services before setting a target. Direct contribution and fully loaded margin answer different decisions — do not use one to make the other.
Inpatient remains the larger dollar base; outpatient is where the growth sits. A softer inpatient year beside a stronger surgical year is often a site-of-care shift, not lost share. Confirm share before adding capacity or cutting a line.
A wide collection gap in self-pay belongs in charity and bad-debt policy. The same gap in commercial or Medicare is contract, denial, or underpayment. Work those two problems on different desks.
If case mix got heavier, expected stay and expected cost should have moved with it. When they did not, documentation and the clinical course are telling different stories — close that gap before the next payment review.
Procedural practices tend to lead contribution dollars; hospital medicine can lead encounters without leading payment rate. Use the view for panel, block, and recruitment planning — not as a public scorecard.
Allowances eased in both settings, and inpatient improved faster. That is not automatically a rate win. If cases also moved outpatient, the hospital average can look better while dollars left the higher-paying setting.
Ancillary departments have a margin, not only a support role. Imaging leads contribution; pharmacy is thinner because drug cost sits on the same line. Read them as businesses when you set targets, prices, and hours.
Maps, payer mix, contractual tables, length of stay versus CMS, Impact Studio, the Navigator, and the executive deck. Hundreds of questions. Each one is a study.
Each card is one decision. The live library covers the rest. Bring the question that has been open for weeks.